TMCnet News
Mersana Therapeutics to Host Conference Call Announcing Fourth Quarter and Full Year 2017 Financial Results and Business UpdatesCAMBRIDGE, Mass., March 21, 2018 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs) based on its Dolaflexin® and other proprietary platforms, today announced that it will host a conference call and webcast on Wednesday, March 28th, 2018, at 8:00 a.m. ET to report financial results for the fourth quarter and full year 2017 and provide business updates. To access the call, please dial 866-363-0156 (domestic) or 706-902-3589 (international) and provide the Conference ID 2057979. A live webcast of the presentation will be available on the Investors & Media section of the Mersana website at www.mersana.com. Abut Mersana Therapeutics Contacts: Media Contact Or Investor Contact |